Glass House Brands (GLAS) EBT Margin Growth (3y) (2024 - 2025)

Glass House Brands (GLAS) EBT Margin Growth (3y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 1,840.00
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -134.00
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -5,626.00
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -1,686.00
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -1,570.00
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 5,487.00
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -225.00
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 3,960.00
Sep 30, 2025 -9,191.00
Jun 30, 2025 7.56 Bn
Jun 30, 2024 9,185.00